-
1
-
-
0028579733
-
Oncogenes and the strategy of growth factors
-
10.1016/0092-8674(94)90023-X 1:CAS:528:DyaK2MXislCgsLs%3D 8001140
-
R Baserga 1994 Oncogenes and the strategy of growth factors Cell 79 927 930 10.1016/0092-8674(94)90023-X 1:CAS:528:DyaK2MXislCgsLs%3D 8001140
-
(1994)
Cell
, vol.79
, pp. 927-930
-
-
Baserga, R.1
-
2
-
-
33748416494
-
Insulin-like growth factor-I receptor as a candidate for a novel molecular target in gastrointestinal cancers
-
DOI 10.1111/j.1443-1661.2006.00657.x
-
Y Adachi H Yamamoto A Imsumran T Oka M Oki K Nosho, et al. 2006 Insulin-like growth factor-I receptor as a candidate for a novel molecular target in the gastrointestinal cancers Dig Endosc 18 245 251 10.1111/j.1443-1661.2006.00657.x (Pubitemid 44341870)
-
(2006)
Digestive Endoscopy
, vol.18
, Issue.4
, pp. 245-251
-
-
Adachi, Y.1
Yamamoto, H.2
Imsumran, A.3
Oka, T.4
Oki, M.5
Nosho, K.6
Min, Y.7
Shinomura, Y.8
Lee, C.-T.9
Carbone, D.P.10
Imai, K.11
-
3
-
-
0025325049
-
Insulin-like growth factors and their binding proteins
-
1:CAS:528:DyaK3cXls1Gnt7c%3D 1694588
-
VR Sara K Hall 1990 Insulin-like growth factors and their binding proteins Physiol Rev 70 591 614 1:CAS:528:DyaK3cXls1Gnt7c%3D 1694588
-
(1990)
Physiol Rev
, vol.70
, pp. 591-614
-
-
Sara, V.R.1
Hall, K.2
-
4
-
-
28544444712
-
Type I insulin-like growth factor receptor as a therapeutic target in cancer
-
DOI 10.1158/0008-5472.CAN-05-2752
-
BS Miller D Yee 2005 Type I insulin-like growth factor receptor as a therapeutic target in cancer Cancer Res 65 10123 10127 10.1158/0008-5472.CAN-05- 2752 1:CAS:528:DC%2BD2MXht1WgurjF 16287993 (Pubitemid 41743697)
-
(2005)
Cancer Research
, vol.65
, Issue.22
, pp. 10123-10127
-
-
Miller, B.S.1
Yee, D.2
-
5
-
-
0022800838
-
Insulin-like growth factor i receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
-
1:CAS:528:DyaL2sXhtl2isw%3D%3D 2877871
-
A Ullrich A Gray AW Tam T Yang-Feng M Tsubokawa C Collins, et al. 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity Embo J 5 2503 2512 1:CAS:528:DyaL2sXhtl2isw%3D%3D 2877871
-
(1986)
Embo J
, vol.5
, pp. 2503-2512
-
-
Ullrich, A.1
Gray, A.2
Tam, A.W.3
Yang-Feng, T.4
Tsubokawa, M.5
Collins, C.6
-
6
-
-
0032127350
-
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
-
1:CAS:528:DyaK1cXksFCqt7g%3D 9661897
-
J Baselga L Norton J Albanell YM Kim J Mendelsohn 1998 Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts Cancer Res 58 2825 2831 1:CAS:528:DyaK1cXksFCqt7g%3D 9661897
-
(1998)
Cancer Res
, vol.58
, pp. 2825-2831
-
-
Baselga, J.1
Norton, L.2
Albanell, J.3
Kim, Y.M.4
Mendelsohn, J.5
-
7
-
-
0034692430
-
Role of the insulin-like growth factor family in cancer development and progression
-
10.1093/jnci/92.18.1472 1:CAS:528:DC%2BD3cXntFKqsrw%3D 10995803
-
H Yu T Rohan 2000 Role of the insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 1472 1489 10.1093/jnci/92.18.1472 1:CAS:528:DC%2BD3cXntFKqsrw%3D 10995803
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1472-1489
-
-
Yu, H.1
Rohan, T.2
-
8
-
-
0026731217
-
Des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells
-
DOI 10.1002/ijc.2910520614
-
M Remacle-Bonnet F Garrouste F el Atiq M Roccabianca J Marvaldi G Pommier 1992 des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells Int J Cancer 52 910 917 10.1002/ijc.2910520614 1:CAS:528:DyaK3sXhs1Wltbs%3D 1281142 (Pubitemid 23009508)
-
(1992)
International Journal of Cancer
, vol.52
, Issue.6
, pp. 910-917
-
-
Remacle-Bonnet, M.1
Garrouste, F.2
El Atiq, F.3
Roccabianca, M.4
Marvaldi, J.5
Pommier, G.6
-
9
-
-
0033531765
-
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
-
10.1093/jnci/91.7.620 1:CAS:528:DyaK1MXislKgs70%3D 10203281
-
J Ma MN Pollak E Giovannucci JM Chan Y Tao CH Hennekens, et al. 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 J Natl Cancer Inst 91 620 625 10.1093/jnci/91.7.620 1:CAS:528:DyaK1MXislKgs70%3D 10203281
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 620-625
-
-
Ma, J.1
Pollak, M.N.2
Giovannucci, E.3
Chan, J.M.4
Tao, Y.5
Hennekens, C.H.6
-
10
-
-
33644506750
-
Min/+ intestinal adenoma progression induced by Igf2 loss of imprinting
-
DOI 10.1158/0008-5472.CAN-05-2036
-
J Harper JL Burns EJ Foulstone M Pignatelli S Zaina AB Hassan 2006 Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting Cancer Res 66 1940 1948 10.1158/0008-5472.CAN-05-2036 1:CAS:528:DC%2BD28XhsFamur8%3D 16488992 (Pubitemid 43294901)
-
(2006)
Cancer Research
, vol.66
, Issue.4
, pp. 1940-1948
-
-
Harper, J.1
Burns, J.L.2
Foulstone, E.J.3
Pignatelli, M.4
Zaina, S.5
Hassan, A.B.6
-
11
-
-
13644262798
-
Insulin-like growth factor ligands, receptors, and binding proteins in cancer
-
DOI 10.1002/path.1712
-
E Foulstone S Prince O Zaccheo JL Burns J Harper C Jacobs, et al. 2005 Insulin-like growth factor ligands, receptors, and binding proteins in cancer J Pathol 205 145 153 10.1002/path.1712 1:CAS:528:DC%2BD2MXhsFOhu7k%3D 15641016 (Pubitemid 40227987)
-
(2005)
Journal of Pathology
, vol.205
, Issue.2
, pp. 145-153
-
-
Foulstone, E.1
Prince, S.2
Zaccheo, O.3
Burns, J.L.4
Harper, J.5
Jacobs, C.6
Church, D.7
Hassan, A.B.8
-
12
-
-
0028890744
-
The insulin-like growth factor i receptor: A key to tumor growth?
-
1:CAS:528:DyaK2MXjtFyjs7g%3D 7812953
-
R Baserga 1995 The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55 249 252 1:CAS:528:DyaK2MXjtFyjs7g%3D 7812953
-
(1995)
Cancer Res
, vol.55
, pp. 249-252
-
-
Baserga, R.1
-
14
-
-
0027496895
-
Mice carrying null mutations of the genes encoding insulin-like growth factor i (Igf-1) and type 1 IGF receptor (Igf1r)
-
1:CAS:528:DyaK2cXps12nsg%3D%3D 8402901
-
JP Liu J Baker AS Perkins EJ Robertson A Efstratiadis 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) Cell 75 59 72 1:CAS:528:DyaK2cXps12nsg%3D%3D 8402901
-
(1993)
Cell
, vol.75
, pp. 59-72
-
-
Liu, J.P.1
Baker, J.2
Perkins, A.S.3
Robertson, E.J.4
Efstratiadis, A.5
-
15
-
-
0026538194
-
Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha
-
1:CAS:528:DyaK38XksVWhtLg%3D 1558785
-
H Lahm L Suardet PL Laurent JR Fischer A Ceyhan JC Givel, et al. 1992 Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha Br J Cancer 65 341 346 1:CAS:528:DyaK38XksVWhtLg%3D 1558785
-
(1992)
Br J Cancer
, vol.65
, pp. 341-346
-
-
Lahm, H.1
Suardet, L.2
Laurent, P.L.3
Fischer, J.R.4
Ceyhan, A.5
Givel, J.C.6
-
16
-
-
0025310235
-
Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: An in vitro model
-
10.1210/endo-126-6-3033 1:CAS:528:DyaK3cXksFeisr4%3D 1693565
-
MA Thompson AJ Cox RH Whitehead HA Jonas 1990 Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in vitro model Endocrinology 126 3033 3042 10.1210/endo-126-6-3033 1:CAS:528: DyaK3cXksFeisr4%3D 1693565
-
(1990)
Endocrinology
, vol.126
, pp. 3033-3042
-
-
Thompson, M.A.1
Cox, A.J.2
Whitehead, R.H.3
Jonas, H.A.4
-
17
-
-
0025892573
-
Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells
-
1:CAS:528:DyaK3MXhslyqu7c%3D 2004373
-
SC Chen CK Chou FH Wong CM Chang CP Hu 1991 Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells Cancer Res 51 1898 1903 1:CAS:528:DyaK3MXhslyqu7c%3D 2004373
-
(1991)
Cancer Res
, vol.51
, pp. 1898-1903
-
-
Chen, S.C.1
Chou, C.K.2
Wong, F.H.3
Chang, C.M.4
Hu, C.P.5
-
18
-
-
34447095442
-
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma
-
DOI 10.1093/carcin/bgl247
-
A Imsumran Y Adachi H Yamamoto R Li Y Wang Y Min, et al. 2007 Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma Carcinogenesis 28 947 956 10.1093/carcin/bgl247 1:CAS:528:DC%2BD2sXlvFGls7c%3D 17183068 (Pubitemid 47072177)
-
(2007)
Carcinogenesis
, vol.28
, Issue.5
, pp. 947-956
-
-
Imsumran, A.1
Adachi, Y.2
Yamamoto, H.3
Li, R.4
Wang, Y.5
Min, Y.6
Piao, W.7
Nosho, K.8
Arimura, Y.9
Shinomura, Y.10
Hosokawa, M.11
Lee, C.-T.12
Carbone, D.P.13
Imai, K.14
-
19
-
-
0023946732
-
Insulin-like growth factor i binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver
-
10.1172/JCI113451 1:CAS:528:DyaL1cXhvVSqtbw%3D 2832449
-
JF Caro J Poulos O Ittoop WJ Pories EG Flickinger MK Sinha 1988 Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver J Clin Invest 81 976 981 10.1172/JCI113451 1:CAS:528:DyaL1cXhvVSqtbw%3D 2832449
-
(1988)
J Clin Invest
, vol.81
, pp. 976-981
-
-
Caro, J.F.1
Poulos, J.2
Ittoop, O.3
Pories, W.J.4
Flickinger, E.G.5
Sinha, M.K.6
-
20
-
-
0029776419
-
Increased expression of the insulin-like growth factor i (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product
-
1:CAS:528:DyaK28XltVKksb4%3D 8706031
-
SO Kim JG Park YI Lee 1996 Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product Cancer Res 56 3831 3836 1:CAS:528:DyaK28XltVKksb4%3D 8706031
-
(1996)
Cancer Res
, vol.56
, pp. 3831-3836
-
-
Kim, S.O.1
Park, J.G.2
Lee, Y.I.3
-
21
-
-
0028997487
-
Insulin-like growth factor i overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles
-
1:CAS:528:DyaK2MXls1OlurY%3D 7743492
-
U Bergmann H Funatomi M Yokoyama HG Beger M Korc 1995 Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles Cancer Res 55 2007 2011 1:CAS:528:DyaK2MXls1OlurY%3D 7743492
-
(1995)
Cancer Res
, vol.55
, pp. 2007-2011
-
-
Bergmann, U.1
Funatomi, H.2
Yokoyama, M.3
Beger, H.G.4
Korc, M.5
-
22
-
-
0033044313
-
Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
-
1:CAS:528:DyaK1MXjtF2ktrk%3D 10205209
-
S Freier O Weiss M Eran A Flyvbjerg R Dahan I Nephesh, et al. 1999 Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon Gut 44 704 708 1:CAS:528:DyaK1MXjtF2ktrk%3D 10205209
-
(1999)
Gut
, vol.44
, pp. 704-708
-
-
Freier, S.1
Weiss, O.2
Eran, M.3
Flyvbjerg, A.4
Dahan, R.5
Nephesh, I.6
-
23
-
-
0035665604
-
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer
-
1:CAS:528:DC%2BD38XislChuw%3D%3D 11813625
-
H Ajisaka S Fushida Y Yonemura K Miwa 2001 Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer Hepatogastroenterology 48 1788 1792 1:CAS:528:DC%2BD38XislChuw%3D%3D 11813625
-
(2001)
Hepatogastroenterology
, vol.48
, pp. 1788-1792
-
-
Ajisaka, H.1
Fushida, S.2
Yonemura, Y.3
Miwa, K.4
-
24
-
-
0032938257
-
Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors
-
1:CAS:528:DyaK1MXislCmtLo%3D 10198323
-
JG Simmons JB Pucilowska PK Lund 1999 Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors Am J Physiol 276 G817 G827 1:CAS:528:DyaK1MXislCmtLo%3D 10198323
-
(1999)
Am J Physiol
, vol.276
-
-
Simmons, J.G.1
Pucilowska, J.B.2
Lund, P.K.3
-
25
-
-
0037115650
-
Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells
-
1:CAS:528:DC%2BD3sXhtV2isA%3D%3D 12499282
-
RJ Levitt M Pollak 2002 Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells Cancer Res 62 7372 7376 1:CAS:528:DC%2BD3sXhtV2isA%3D%3D 12499282
-
(2002)
Cancer Res
, vol.62
, pp. 7372-7376
-
-
Levitt, R.J.1
Pollak, M.2
-
26
-
-
0037131385
-
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
-
DOI 10.1074/jbc.M202766200
-
G Pandini F Frasca R Mineo L Sciacca R Vigneri A Belfiore 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved J Biol Chem 277 39684 39695 10.1074/jbc.M202766200 1:CAS:528:DC%2BD38XnvVeiu74%3D 12138094 (Pubitemid 35190951)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.42
, pp. 39684-39695
-
-
Pandini, G.1
Frasca, F.2
Mineo, R.3
Sciacca, L.4
Vigneri, R.5
Belfiore, A.6
-
27
-
-
57749089652
-
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival
-
10.1158/0008-5472.CAN-08-2755 1:CAS:528:DC%2BD1cXhsV2itL7K 19074892
-
JH Law G Habibi K Hu H Masoudi MY Wang AL Stratford, et al. 2008 Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival Cancer Res 68 10238 10246 10.1158/0008-5472.CAN-08-2755 1:CAS:528:DC%2BD1cXhsV2itL7K 19074892
-
(2008)
Cancer Res
, vol.68
, pp. 10238-10246
-
-
Law, J.H.1
Habibi, G.2
Hu, K.3
Masoudi, H.4
Wang, M.Y.5
Stratford, A.L.6
-
28
-
-
23244462857
-
Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps
-
16083703
-
RE Schoen JL Weissfeld LH Kuller FL Thaete RW Evans RB Hayes, et al. 2005 Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps Gastroenterology 129 464 475 16083703
-
(2005)
Gastroenterology
, vol.129
, pp. 464-475
-
-
Schoen, R.E.1
Weissfeld, J.L.2
Kuller, L.H.3
Thaete, F.L.4
Evans, R.W.5
Hayes, R.B.6
-
29
-
-
9144234724
-
A fully human monoclonal antibody to the insulin-like growth factor i receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo
-
1:CAS:528:DC%2BD3sXhtVSqtbvL 14695208
-
D Burtrum Z Zhu D Lu DM Anderson M Prewett DS Pereira, et al. 2003 A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo Cancer Res 63 8912 8921 1:CAS:528:DC%2BD3sXhtVSqtbvL 14695208
-
(2003)
Cancer Res
, vol.63
, pp. 8912-8921
-
-
Burtrum, D.1
Zhu, Z.2
Lu, D.3
Anderson, D.M.4
Prewett, M.5
Pereira, D.S.6
-
30
-
-
20144386856
-
Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871
-
DOI 10.1158/1078-0432.CCR-04-1070
-
BD Cohen DA Baker C Soderstrom G Tkalcevic AM Rossi PE Miller, et al. 2005 Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751, 871 Clin Cancer Res 11 2063 2073 10.1158/1078-0432.CCR-04-1070 1:CAS:528:DC%2BD2MXitVKrtr0%3D 15756033 (Pubitemid 40471873)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.5
, pp. 2063-2073
-
-
Cohen, B.D.1
Baker, D.A.2
Soderstrom, C.3
Tkalcevic, G.4
Rossi, A.M.5
Miller, P.E.6
Tengowski, M.W.7
Wang, F.8
Gualberto, A.9
Beebe, J.S.10
Moyer, J.D.11
-
31
-
-
23844521596
-
Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody
-
DOI 10.1158/1535-7163.MCT-05-0048
-
Y Wang J Hailey D Williams P Lipari M Malkowski X Wang, et al. 2005 Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody Mol Cancer Ther 4 1214 1221 10.1158/1535-7163.MCT-05-0048 1:CAS:528:DC%2BD2MXnt1ShtLg%3D 16093437 (Pubitemid 41149569)
-
(2005)
Molecular Cancer Therapeutics
, vol.4
, Issue.8
, pp. 1214-1221
-
-
Wang, Y.1
Hailey, J.2
Williams, D.3
Wang, Y.4
Lipari, P.5
Malkowski, M.6
Wang, X.7
Xie, L.8
Li, G.9
Saha, D.10
Ling, W.L.W.11
Cannon-Carlson, S.12
Greenberg, R.13
Ramos, R.A.14
Shields, R.15
Presta, L.16
Brams, P.17
Bishop, W.R.18
Pachter, J.A.19
-
32
-
-
49849098247
-
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas
-
10.1158/1535-7163.MCT-07-2395 1:CAS:528:DC%2BD1cXnsVSktL8%3D 18566219
-
W Piao Y Wang Y Adachi H Yamamoto R Li A Imsumran, et al. 2008 Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas Mol Cancer Ther 7 1483 1493 10.1158/1535-7163.MCT-07-2395 1:CAS:528:DC%2BD1cXnsVSktL8%3D 18566219
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 1483-1493
-
-
Piao, W.1
Wang, Y.2
Adachi, Y.3
Yamamoto, H.4
Li, R.5
Imsumran, A.6
-
33
-
-
58249101005
-
The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors
-
10.1158/0008-5472.CAN-08-0835 1:CAS:528:DC%2BD1MXmvFCi 19117999
-
F Huang A Greer W Hurlburt X Han R Hafezi GM Wittenberg, et al. 2009 The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors Cancer Res 69 161 170 10.1158/0008-5472.CAN-08-0835 1:CAS:528:DC%2BD1MXmvFCi 19117999
-
(2009)
Cancer Res
, vol.69
, pp. 161-170
-
-
Huang, F.1
Greer, A.2
Hurlburt, W.3
Han, X.4
Hafezi, R.5
Wittenberg, G.M.6
-
34
-
-
0036787432
-
Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines
-
10.1053/gast.2002.36023 1:CAS:528:DC%2BD38Xotl2ns74%3D 12360481
-
Y Adachi CT Lee K Coffee N Yamagata JE Ohm KH Park, et al. 2002 Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines Gastroenterology 123 1191 1204 10.1053/gast.2002.36023 1:CAS:528:DC%2BD38Xotl2ns74%3D 12360481
-
(2002)
Gastroenterology
, vol.123
, pp. 1191-1204
-
-
Adachi, Y.1
Lee, C.T.2
Coffee, K.3
Yamagata, N.4
Ohm, J.E.5
Park, K.H.6
-
35
-
-
0141988681
-
Genetic blockade of the insulin-like growth factor-I receptor: A promising strategy for human pancreatic cancer
-
1:CAS:528:DC%2BD3sXotV2isrc%3D 14559833
-
Y Min Y Adachi H Yamamoto H Ito F Itoh CT Lee, et al. 2003 Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer Cancer Res 63 6432 6441 1:CAS:528:DC%2BD3sXotV2isrc%3D 14559833
-
(2003)
Cancer Res
, vol.63
, pp. 6432-6441
-
-
Min, Y.1
Adachi, Y.2
Yamamoto, H.3
Ito, H.4
Itoh, F.5
Lee, C.T.6
-
36
-
-
20244366701
-
Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts
-
DOI 10.1136/gut.2004.048926
-
Y Min Y Adachi H Yamamoto A Imsumran Y Arimura T Endo, et al. 2005 Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts Gut 54 591 600 10.1136/gut.2004.048926 1:CAS:528:DC%2BD2MXktlOjtrw%3D 15831900 (Pubitemid 40559239)
-
(2005)
Gut
, vol.54
, Issue.5
, pp. 591-600
-
-
Min, Y.1
Adachi, Y.2
Yamamoto, H.3
Imsumran, A.4
Arimura, Y.5
Endo, T.6
Hinoda, Y.7
Lee, C.-T.8
Nadaf, S.9
Carbone, D.P.10
Imai, K.11
-
37
-
-
0032545933
-
Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans
-
DOI 10.1038/35888
-
A Fire S Xu MK Montgomery SA Kostas SE Driver CC Mello 1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 806 811 10.1038/35888 1:CAS:528:DyaK1cXhtlCju74%3D 9486653 (Pubitemid 28099681)
-
(1998)
Nature
, vol.391
, Issue.6669
, pp. 806-811
-
-
Fire, A.1
Xu, S.2
Montgomery, M.K.3
Kostas, S.A.4
Driver, S.E.5
Mello, C.C.6
-
38
-
-
0037062951
-
RNA interference
-
DOI 10.1038/418244a
-
GJ Hannon 2002 RNA interference Nature 418 244 251 10.1038/418244a 1:CAS:528:DC%2BD38XltFGmu7Y%3D 12110901 (Pubitemid 34773784)
-
(2002)
Nature
, vol.418
, Issue.6894
, pp. 244-251
-
-
Hannon, G.J.1
-
39
-
-
0037448593
-
Functional genomics: RNA sets the standard
-
DOI 10.1038/421220a
-
T Tuschl 2003 Functional genomics: RNA sets the standard Nature 421 220 221 10.1038/421220a 1:CAS:528:DC%2BD3sXjsF2jug%3D%3D 12529623 (Pubitemid 36139111)
-
(2003)
Nature
, vol.421
, Issue.6920
, pp. 220-221
-
-
Tuschl, T.1
-
40
-
-
0038521255
-
The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript
-
DOI 10.1074/jbc.M300714200
-
EA Bohula AJ Salisbury M Sohail MP Playford J Riedemann EM Southern, et al. 2003 The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript J Biol Chem 278 15991 15997 10.1074/jbc.M300714200 1:CAS:528:DC%2BD3sXjt1ehsb0%3D 12604614 (Pubitemid 36799718)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.18
, pp. 15991-15997
-
-
Bohula, E.A.1
Salisbury, A.J.2
Sohail, M.3
Playford, M.P.4
Riedemann, J.5
Southern, E.M.6
Macaulay, V.M.7
-
41
-
-
10844296820
-
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer
-
DOI 10.1038/sj.cgt.7700775
-
MA Rochester J Riedemann GO Hellawell SF Brewster VM Macaulay 2005 Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer Cancer Gene Ther 12 90 100 10.1038/sj.cgt.7700775 1:CAS:528:DC%2BD2cXhtVOht77O 15499378 (Pubitemid 39665247)
-
(2005)
Cancer Gene Therapy
, vol.12
, Issue.1
, pp. 90-100
-
-
Rochester, M.A.1
Riedemann, J.2
Hellawell, G.O.3
Brewster, S.F.4
Macaulay, V.M.5
-
42
-
-
45349102931
-
Knockdown of insulin-like growth factor 1 receptor enhances chemosensitivity to cisplatin in human lung adenocarcinoma A549 cells
-
DOI 10.1111/j.1745-7270.2008.00429.x
-
A Dong M Kong Z Ma J Qian H Cheng X Xu 2008 Knockdown of insulin-like growth factor 1 receptor enhances chemosensitivity to cisplatin in human lung adenocarcinoma A549 cells Acta Biochim Biophys Sin (Shanghai) 40 497 504 10.1111/j.1745-7270.2008.00429.x 1:CAS:528:DC%2BD1cXpt1aqu7k%3D (Pubitemid 351847346)
-
(2008)
Acta Biochimica et Biophysica Sinica
, vol.40
, Issue.6
, pp. 497-504
-
-
Dong, A.1
Kong, M.2
Ma, Z.3
Qian, J.4
Cheng, H.5
Xu, X.6
-
43
-
-
33847421317
-
Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway
-
DOI 10.1016/j.lungcan.2006.10.020, PII S0169500206006027
-
YJ Lee A Imsumran MY Park SY Kwon HI Yoon JH Lee, et al. 2007 Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway Lung Cancer 55 279 286 10.1016/j.lungcan.2006. 10.020 17134788 (Pubitemid 46343577)
-
(2007)
Lung Cancer
, vol.55
, Issue.3
, pp. 279-286
-
-
Lee, Y.-J.1
Imsumran, A.2
Park, M.-Y.3
Kwon, S.-Y.4
Yoon, H.I.5
Lee, J.-H.6
Yoo, C.-G.7
Kim, Y.W.8
Han, S.K.9
Shim, Y.-S.10
Piao, W.11
Yamamoto, H.12
Adachi, Y.13
Carbone, D.P.14
Lee, C.-T.15
-
44
-
-
0029895283
-
Antitumor effects of an adenovirus expressing antisense insulin-like growth factor i receptor on human lung cancer cell lines
-
1:CAS:528:DyaK28XjvFCkt7w%3D 8674059
-
CT Lee S Wu D Gabrilovich H Chen S Nadaf-Rahrov IF Ciernik, et al. 1996 Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines Cancer Res 56 3038 3041 1:CAS:528:DyaK28XjvFCkt7w%3D 8674059
-
(1996)
Cancer Res
, vol.56
, pp. 3038-3041
-
-
Lee, C.T.1
Wu, S.2
Gabrilovich, D.3
Chen, H.4
Nadaf-Rahrov, S.5
Ciernik, I.F.6
-
45
-
-
0028070655
-
Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
-
DOI 10.1002/ijc.2910580325
-
H Lahm P Amstad J Wyniger A Yilmaz JR Fischer M Schreyer, et al. 1994 Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop Int J Cancer 58 452 459 10.1002/ijc.2910580325 1:CAS:528:DyaK2cXlslKgtbw%3D 8050827 (Pubitemid 24254660)
-
(1994)
International Journal of Cancer
, vol.58
, Issue.3
, pp. 452-459
-
-
Lahm, H.1
Amstad, P.2
Wyniger, J.3
Yilmaz, A.4
Fischer, J.R.5
Schreyer, M.6
Givel, J.-C.7
-
46
-
-
60549112878
-
Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta
-
10.1158/0008-5472.CAN-08-1328 1:CAS:528:DC%2BD1MXhslynsrk%3D 19190347
-
J Kwon S Stephan A Mukhopadhyay MH Muders SK Dutta JS Lau, et al. 2009 Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta Cancer Res 69 1350 1357 10.1158/0008-5472.CAN-08-1328 1:CAS:528:DC%2BD1MXhslynsrk%3D 19190347
-
(2009)
Cancer Res
, vol.69
, pp. 1350-1357
-
-
Kwon, J.1
Stephan, S.2
Mukhopadhyay, A.3
Muders, M.H.4
Dutta, S.K.5
Lau, J.S.6
-
47
-
-
0035915421
-
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)
-
10.1093/jnci/93.24.1852 1:CAS:528:DC%2BD38XltVWluw%3D%3D 11752009
-
Y Lu X Zi Y Zhao D Mascarenhas M Pollak 2001 Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) J Natl Cancer Inst 93 1852 1857 10.1093/jnci/93.24.1852 1:CAS:528:DC%2BD38XltVWluw%3D%3D 11752009
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1852-1857
-
-
Lu, Y.1
Zi, X.2
Zhao, Y.3
Mascarenhas, D.4
Pollak, M.5
-
48
-
-
28244432561
-
Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells
-
DOI 10.1158/0008-5472.CAN-04-3841
-
R Nahta LX Yuan B Zhang R Kobayashi FJ Esteva 2005 Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells Cancer Res 65 11118 11128 10.1158/0008-5472.CAN-04-3841 1:CAS:528:DC%2BD2MXht1KjsrrI 16322262 (Pubitemid 41713383)
-
(2005)
Cancer Research
, vol.65
, Issue.23
, pp. 11118-11128
-
-
Nahta, R.1
Yuan, L.X.H.2
Zhang, B.3
Kobayashi, R.4
Esteva, F.J.5
-
49
-
-
0033906634
-
Structure and function of the type 1 insulin-like growth factor receptor
-
10.1007/PL00000744 1:CAS:528:DC%2BD3cXmt1Omsr0%3D 10961344
-
TE Adams VC Epa TP Garrett CW Ward 2000 Structure and function of the type 1 insulin-like growth factor receptor Cell Mol Life Sci 57 1050 1093 10.1007/PL00000744 1:CAS:528:DC%2BD3cXmt1Omsr0%3D 10961344
-
(2000)
Cell Mol Life Sci
, vol.57
, pp. 1050-1093
-
-
Adams, T.E.1
Epa, V.C.2
Garrett, T.P.3
Ward, C.W.4
-
50
-
-
33846458639
-
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
-
DOI 10.1158/0008-5472.CAN-06-1712
-
H Zhang AM Pelzer DT Kiang D Yee 2007 Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin Cancer Res 67 391 397 10.1158/0008-5472.CAN-06-1712 1:CAS:528:DC%2BD2sXisFWjsw%3D%3D 17210722 (Pubitemid 46142798)
-
(2007)
Cancer Research
, vol.67
, Issue.1
, pp. 391-397
-
-
Zhang, H.1
Pelzer, A.M.2
Kiang, D.T.3
Yee, D.4
|